In This Article:
On Tuesday, January 7, 2025, shares of vaccine firms rose with Moderna (NASDAQ:MRNA) led by 11.6% uptick as more Americans concerned with the surge of Covid-19 and flu infections threats.
Immunization-focused businesses were in high demand as the CDC encouraged Americans to get recommended vaccinations on rising COVID-19 activity as well as flu cases among young children, thus investor attention.
While there is a bullish sentiment today, Benzinga detected bearish stance on Moderna's options trading from days before. As per January 3, there were 6 put options amounting $535,114 compared to 7 call options for a total amount $515,486. Fewer bearish bets with higher amount of money can be translated as investors' appetite in betting against Moderna.
This article first appeared on GuruFocus.